JP2016510041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510041A5 JP2016510041A5 JP2015560385A JP2015560385A JP2016510041A5 JP 2016510041 A5 JP2016510041 A5 JP 2016510041A5 JP 2015560385 A JP2015560385 A JP 2015560385A JP 2015560385 A JP2015560385 A JP 2015560385A JP 2016510041 A5 JP2016510041 A5 JP 2016510041A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- semi
- excipient
- solid gel
- local anesthetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 35
- 239000007787 solid Substances 0.000 claims 25
- 239000000546 pharmaceutical excipient Substances 0.000 claims 24
- 239000003589 local anesthetic agent Substances 0.000 claims 21
- 125000005456 glyceride group Chemical group 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 238000004090 dissolution Methods 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 229920006395 saturated elastomer Polymers 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims 3
- 229930195729 fatty acid Natural products 0.000 claims 3
- 239000000194 fatty acid Substances 0.000 claims 3
- 150000004665 fatty acids Chemical class 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 3
- 238000002347 injection Methods 0.000 claims 3
- 239000007924 injection Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- OIQOAYVCKAHSEJ-UHFFFAOYSA-N 2-[2,3-bis(2-hydroxyethoxy)propoxy]ethanol;hexadecanoic acid;octadecanoic acid Chemical compound OCCOCC(OCCO)COCCO.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O OIQOAYVCKAHSEJ-UHFFFAOYSA-N 0.000 claims 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 150000001261 hydroxy acids Chemical class 0.000 claims 2
- 239000002736 nonionic surfactant Substances 0.000 claims 2
- 231100000252 nontoxic Toxicity 0.000 claims 2
- 230000003000 nontoxic effect Effects 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims 2
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 claims 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims 1
- VTUSIVBDOCDNHS-UHFFFAOYSA-N Etidocaine Chemical compound CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C VTUSIVBDOCDNHS-UHFFFAOYSA-N 0.000 claims 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 229960003150 bupivacaine Drugs 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229960003976 etidocaine Drugs 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- 239000002563 ionic surfactant Substances 0.000 claims 1
- 229960004194 lidocaine Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960002409 mepivacaine Drugs 0.000 claims 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 claims 1
- 229960001549 ropivacaine Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000008299 semisolid dosage form Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361771011P | 2013-02-28 | 2013-02-28 | |
| US61/771,011 | 2013-02-28 | ||
| PCT/US2014/019704 WO2014134586A2 (en) | 2013-02-28 | 2014-02-28 | Injectable long-acting local anesthetic semi-solid formulations and its compostions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016510041A JP2016510041A (ja) | 2016-04-04 |
| JP2016510041A5 true JP2016510041A5 (enExample) | 2016-05-19 |
| JP6363115B2 JP6363115B2 (ja) | 2018-07-25 |
Family
ID=50288331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015560385A Expired - Fee Related JP6363115B2 (ja) | 2013-02-28 | 2014-02-28 | 注射可能局所麻酔半固体製剤およびその組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10500281B2 (enExample) |
| EP (1) | EP2961380B1 (enExample) |
| JP (1) | JP6363115B2 (enExample) |
| KR (1) | KR101768843B1 (enExample) |
| CN (1) | CN105120839B (enExample) |
| AU (1) | AU2014223993B2 (enExample) |
| CA (1) | CA2903020C (enExample) |
| WO (1) | WO2014134586A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9849180B2 (en) | 2014-09-15 | 2017-12-26 | Hui Rong Shen | Long-acting semi-solid lipid formulations |
| EP2961380B1 (en) | 2013-02-28 | 2020-04-08 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid formulations and its compositions |
| US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
| US20170296484A1 (en) * | 2015-11-23 | 2017-10-19 | Grace Therapeutics Llc | Topical Film-Forming Spray |
| EP3452119A1 (en) * | 2016-05-02 | 2019-03-13 | The General Hospital Corporation | Implant surfaces for pain control |
| EP3558279A4 (en) * | 2016-12-26 | 2020-12-02 | Cellix Bio Private Limited | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN |
| JP7046396B2 (ja) * | 2017-12-06 | 2022-04-04 | 湖州惠中濟世生物科技有限公司 | 注射可能な長時間作用性局所麻酔薬半固形製剤 |
| US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
| US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
| CN113262302B (zh) * | 2020-02-17 | 2022-12-09 | 湖州惠中济世生物科技有限公司 | 可注射长效半固体凝胶制剂 |
| EP4284272A4 (en) * | 2021-01-29 | 2024-12-25 | Insitu Biologics, Inc. | COMPOSITIONS AND METHODS OF SUSTAINED TREATMENT OF PAIN |
| JP2023027715A (ja) * | 2021-08-17 | 2023-03-02 | 株式会社カネカ | 医薬組成物、及び貼付剤 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775659A (en) * | 1985-08-19 | 1988-10-04 | Eli Lilly And Company | Injectable semi-solid formulations |
| SE9200952D0 (sv) | 1992-03-27 | 1992-03-27 | Kabi Pharmacia Ab | Pharmaceutical carrier system containing defined lipids |
| US5700485A (en) | 1992-09-10 | 1997-12-23 | Children's Medical Center Corporation | Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
| JPH08143449A (ja) * | 1994-11-17 | 1996-06-04 | Lederle Japan Ltd | 徐放性局所麻酔用注射剤 |
| US6413536B1 (en) | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
| CN1156961A (zh) | 1995-06-09 | 1997-08-13 | 欧罗赛铁克股份有限公司 | 产生长效局部麻醉的制剂和方法 |
| GB9610862D0 (en) * | 1996-05-23 | 1996-07-31 | Evans Brian K | Pharmaceutical products |
| ES2373861T3 (es) | 1997-09-18 | 2012-02-09 | Pacira Pharmaceuticals, Inc. | Composiciones anestésicas liposomiales de liberación sostenida. |
| AU781682B2 (en) * | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
| US6613355B2 (en) | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| GB0015617D0 (en) | 2000-06-26 | 2000-08-16 | Vectura Ltd | Improved preparations for dermal delivery of active substances |
| DE10033059A1 (de) * | 2000-07-07 | 2002-01-31 | Wacker Chemie Gmbh | Komplexe aus gamma-Cyclodextrin und Benzocain, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| US20040001889A1 (en) * | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| US20070184089A1 (en) * | 2002-07-15 | 2007-08-09 | Alcon, Inc. | Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use |
| US8221778B2 (en) | 2005-01-12 | 2012-07-17 | The Trustees Of The University Of Pennsylvania | Drug-containing implants and methods of use thereof |
| US7666914B2 (en) | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
| GB0524958D0 (en) * | 2005-12-07 | 2006-01-18 | Pharmakodex Ltd | Transdermal administration of active agents |
| PL3085363T3 (pl) | 2007-03-28 | 2019-08-30 | Innocoll Pharmaceuticals Limited | Urządzenie dostarczające lek dla zapewnienia miejscowej analgezji, miejscowego znieczulenia lub blokady nerwowej |
| CN102458388B (zh) | 2009-06-11 | 2016-09-28 | 光治疗Asa公司 | 半固体组合物及药物制品 |
| WO2011075623A1 (en) | 2009-12-18 | 2011-06-23 | Latitude Pharmaceuticals, Inc. | One - phase gel compos ition compri s ing phos pholi pids |
| SG184072A1 (en) * | 2010-04-01 | 2012-10-30 | Pharmanest Ab | Bioadhesive compositions of local anaesthetics |
| WO2011121034A2 (en) * | 2010-04-01 | 2011-10-06 | Pharmanest Ab | Water-free pharmaceutical compositions suitable for local anaesthetics |
| WO2011121074A1 (en) * | 2010-04-01 | 2011-10-06 | Pharmanest Ab | Thermogelling anaesthetic compositions |
| EP2961380B1 (en) | 2013-02-28 | 2020-04-08 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid formulations and its compositions |
| DK3134068T3 (da) | 2014-04-21 | 2021-10-04 | Heron Therapeutics Inc | Langtidsvirkende polymerafgivelsessystemer |
-
2014
- 2014-02-28 EP EP14710751.0A patent/EP2961380B1/en active Active
- 2014-02-28 CA CA2903020A patent/CA2903020C/en not_active Expired - Fee Related
- 2014-02-28 WO PCT/US2014/019704 patent/WO2014134586A2/en not_active Ceased
- 2014-02-28 AU AU2014223993A patent/AU2014223993B2/en not_active Ceased
- 2014-02-28 JP JP2015560385A patent/JP6363115B2/ja not_active Expired - Fee Related
- 2014-02-28 CN CN201480011256.0A patent/CN105120839B/zh active Active
- 2014-02-28 KR KR1020157026862A patent/KR101768843B1/ko not_active Expired - Fee Related
-
2015
- 2015-08-28 US US14/839,352 patent/US10500281B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016510041A5 (enExample) | ||
| JP3689791B2 (ja) | タキソイドに基づく新規な組成物 | |
| TWI641395B (zh) | 注射製劑 | |
| JP2020519661A5 (enExample) | ||
| JP2013523694A5 (enExample) | ||
| JP6029472B2 (ja) | ソマトスタチン類似体（アナログ）の持続的放出のための医薬組成物の製造方法 | |
| JP2018505169A5 (enExample) | ||
| CN108601843A (zh) | 控释制剂 | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| RU2013113222A (ru) | Способы лечения или профилактики тромбообразования или эмболии | |
| JP2013534244A5 (enExample) | ||
| RU2013128430A (ru) | Композиции ротиготина, их производных или фармацевтически приемлемых солей ротиготина или их производных | |
| BR112012022746B1 (pt) | Uso de amissulprida como anti-emético | |
| SMT201300101B (it) | Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio | |
| JP2015504924A5 (enExample) | ||
| JP2016526039A5 (enExample) | ||
| CA2869676A1 (en) | Uses and compositions comprising a thiazolidinedione and oleic acid for locally increasing subcutaneous fat | |
| JP2011518787A5 (enExample) | ||
| WO2003004024A1 (en) | Injectable sustained-release microspheres of huperzine a compounds | |
| MY157513A (en) | A water-in-oil type emulsion for treating a disease of the eye | |
| CA3137819A1 (en) | Sustained-release microparticles containing deslorelin, and preparation method therefor | |
| JP2019537589A5 (enExample) | ||
| EP3723741A1 (en) | Dissolution of monosodium urate to treat gout | |
| TW200800177A (en) | Aqueous pharmaceutical formulations of ERβ selective ligands | |
| JP2019513828A5 (enExample) |